BioInvent International AB (Bioinvent) and Les Laboratoires Servier (Servier) have entered into an antibody collaboration on an oncology target involved in tumour cell metabolism provided by Servier. BioInvent will receive a licensing fee, research support and potential milestone payments of more than EUR 11m, as well as royalty on future sales of the product.

The importance of biotechnologies in the health sector in the Nordic countries and their international reputation brings a French delegation to Lund on the 4th of October.

More than 330 innovation specialists attended the 4th edition of the “Rencontre Nationale des Directeurs de l’Innovation” in Paris, 19 - 20 April. Medicon Valley was in focus through out the programme and Anna Chérouvrier Hansson from Invest in Skåne was invited as a key speaker to present the journey of Medicon Valley and its achievements.